Generics Industry News Search
 |
|
|
|
|
|
|
January 2015 News Archive |
|
|
| |
|
Torrent Pharmaceuticals has signed a licensing agreement with Reliance Life Sciences for the marketing of three biosimilar products in India...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
PL Developments announced today that they have received FDA approval to manufacture Ibuprofen...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced the U.S. launch of its Valsartan tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Jubilant Life Sciences, an integrated Pharmaceuticals and Life Sciences Company, has received ANDA final approval from the U.S. FDA for Mycophenolate mofetil...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Lupin announced today that it has launched its Valsartan tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva Pharmaceuticals announces the FDA approval and the launch of the generic equivalent to Diovan (Valsartan) Tablets in the United States...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Patent Office has set aside its earlier order granting patent to Abbott Biotechnology Ltd's rheumatoid arthritis drug Humira...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva Pharmaceutical has launched generic versions of two antibiotics in the US...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Jubilant Life Sciences, an integrated Pharmaceuticals and Life Sciences Company, announced today that it has received ANDA final approval from the...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Aurobindo Pharma is pleased to announce that the company has received final approval from the U.S. FDA to manufacture and market Valsartan tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Hospira Japan, announced today the approval of two new generic oncology drugs...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
A panel to the U.S. Food and Drug Administration unanimously backed the approval of Novartis AG's copy of Amgen's blockbuster cancer drug Neupogen...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Hikma today notes that Takeda has been unsuccessful in appealing the decision...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
In a move that may be a damper for patients suffering from lung and respiratory diseases, the Delhi high court has decided in favour of drug MNC Novartis...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Perrigo today announced that it has launched its AB therapeutic equivalent Testosterone gel...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Perrigo today announced that it has launched Clobetasol propionate spray...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Hospira today announced that it has submitted a Biologics License Application to the FDA for Retacrit...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Prasco, Takeda, and Takeda's wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A. announced today that Prasco and TPUSA have entered into a distribution and supply agreement for the rights to distribute Colchicine Tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Helsinn Healthcare announces that it has entered into a settlement agreement with Sandoz to resolve their patent litigations relating to Helsinn Healthcare...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Takeda Pharmaceutical Company, and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A. (TPUSA) stated today that TPUSA will continue its patent infringement litigation against Hikma Pharmaceuticals...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The patent dispute between US-based pharma major Bristol Myers Squibb (BMS) and Indian pharma company Natco Pharm over Entecavir...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Cipla today moved the Delhi High Court challenging its order temporarily restraining it from manufacturing or selling any drug containing the chemical Indacaterol...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis announced the launch of a leading portfolio of generic specialty injectable medications to be marketed to hospitals across the United States...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
In an unusual move, Pfizer has written to physician groups in the U.K. to warn that prescribing generic versions of its Lyrica medicine - specifically, for treating pain - would violate its patent...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
In November 2012, the federal patent court in Germany ruled a key patent on Seroquel, the extended-release version of Seroquel...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Veloxis today confirmed that the U.S. District Court for the District of Columbia has set a briefing schedule...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
India's patent office has rejected an application from Gilead for its hepatitis C drug Sovaldi...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
After a federal appeals court ruled in June that its existing patents for an eyelash growth treatment were invalid...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced the U.S. launch of its Lamivudine tablets, 100 mg, which is the generic version of GlaxoSmithKline's Epivir-HBV...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
In another disappointment for Mumbai- based drug maker Cipla, Delhi High Court division bench has refused to give any interim relief to the company against a recent order by Delhi High Court barring the company to sell cheaper generic of Novartis' respiratory drug Onbrez...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Elite Pharmaceuticals today announced the first shipments of generic Isradipine 2.5 mg and 5.0 mg capsules. Isradipine is a calcium channel blocker prescribed for hypertension...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Akorn today confirmed that it has filed an ANDA with the U.S. FDA seeking approval to market Difluprednate ophthalmic emulsion 0.05%...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Orexo today announced that it has, together with its partner Galena Biopharma, received a "Paragraph IV"...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Supernus Pharmaceuticals announced that it sued generic drug makers Par Pharmaceutical Companies for infringement of four patents covering its antiepileptic drug Trokendi...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The EMA is ready to share its assessments of applications for generic medicines in real time with collaborating regulatory agencies outside the EU...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Fresenius Kabi announced it has received approval from the FDA to market Neostigmine methylsulfate injection, the generic version of Eclat's Bloxiverz...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis has another drug recall to deal with, this one involving nearly 65,000 bottles of the generic version of the seizure drug Neurontin that it manufactures at a plant in India...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva today announced the U.S. Supreme Court's decision in Teva Pharmaceuticals USA, Petitioners v. Sandoz that reversed the Federal Circuit Court's judgment of invalidity of Teva's '808 patent for Copaxone 20 mg/mL...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Strides Arcolab Limited has entered into a licensing agreement with Gilead Sciences, under which Gilead has extended non-exclusive rights to the Indian firm to manufacture and distribute Tenofovir Alafenamide, both as a single agent product and in combination with other drugs, as per a company release....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Delhi High Court on Monday restrained Mumbai-based generic drug maker Glenmark Pharmaceuticals from manufacturing and selling, directly or indirectly, Linezolid, manufactured through the process patented by the Hyderabad-based pharma company Symed Laboratories...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Samsung Bioepis today announced that the marketing authorisation application for its Enbrel biosimilar candidate, SB4 has been validated and accepted for review by European Medicines Agency...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Australia's medicines regulator, the TGA, has announced it will no longer implement a planned update to the way in which it names biosimilar products following a proposal by WHO to change a naming standard on which Australia relied for its policy...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Supernus Pharmaceuticals announced that it sued generic drug makers TWi Pharmaceuticals for infringement of four patents covering its antiepileptic drug Oxtellar XR...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Innovent Biologics has raised $100 million in venture cash in hopes of becoming the premier maker of biotech drugs in its native China, advancing a pipeline of biosimilars and proprietary treatments...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Hanwha Chemical is exporting the technology to make generic drugs for arthritis treatments...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva Pharmaceutical Industries today announced the FDA's approval of the first generic equivalent to Nexium delayed-release capsules in the United States...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Impax Laboratories announced today that the FDA has approved generic Lamictal orally disintegrating tablets, 25mg, 50mg, 100mg and 200mg in blister packaging...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Antares Pharma, today announced that the FDA has issued a complete response letter regarding the ANDA for Sumatriptan Injection for the acute treatment of migraine...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Supreme Court on Monday sent three patent cases, including one dispute over Shire Plc's Lialda drug, back to a lower court for further proceedings in light of a ruling the justices issued last week...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The rivals of Teva Pharmaceutical Industries who are developing a generic version of multiple sclerosis treatment Copaxone, have urged the US Supreme Court to expedite sending the case back to the appellate court...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Ranbaxy Laboratories has lost the opportunity to exclusively market in the United States for six months, the first generic version of Astra Zeneca's heartburn drug Nexium, the Delhi-based company said in a filing to the stock exchange on Tuesday...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Swiss pharma company Novartis has raised objections to Wockhardt filing additional documents in a revocation petition by the latter against the former's patent for anti-diabetes drug Vildagliptin...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
ANI Pharmaceuticals today announced the launch of Etodolac 300mg oral capsules, indicated for use in the management of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and acute pain...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva announced the launch of Metoclopramide Injection, the generic version of Baxter's Reglan injection...
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
